حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Aiforia Technologies Oyj
AIFORIAAiforia Technologies Oyj, together with its subsidiary Aiforia Inc., equips pathologists and scientists in preclinical, clinical, and academic labs with deep learning artificial intelligence (AI) software for translating images into discoveries, decisions, and diagnoses in Finland, rest of Europe, North America, and internationally. The company offers AI-supported image-based diagnostic suites for breast cancer, lung cancer, and prostate cancer. It also provides Aiforia Create, which allows users to create and validate their own proprietary deep learning AI models, as well as train their AI models to identify, quantify, or measure features in any 2D image; and Aiforia Studies, a software module that offers AI-assisted image analysis workflow within the framework of good laboratory practices. In addition, the company offers integration, cloud hosting, and custom AI services. It serves pharmaceutical and biotechnology companies, contract research organizations, clinical laboratories, academic institutions, and other industries. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland. Address: Pursimiehenkatu 29-31 D 610, Helsinki, Finland, 00150
Analytics
سعر الهدف في وول ستريت
5.03 EURنسبة السعر إلى الأرباح
–العائد الربحي
–السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية AIFORIA
تحليلات الأرباح AIFORIA
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
–معدل الدفع 5 سنوات في المتوسط
–تاريخ الأرباح AIFORIA
تقييم الأسهم AIFORIA
المالية AIFORIA
نتائج | 2019 | ديناميات |